APA (7th ed.) Citation

Shan, X., Zhang, C., Li, C., Fan, X., Song, G., Zhu, J., . . . Zhu, W. (2023). miR-338-3p acts as a tumor suppressor in lung squamous cell carcinoma by targeting FGFR2/FRS2. Cancer pathogenesis and therapy, 1(2), 87-97. https://doi.org/10.1016/j.cpt.2022.12.004

Chicago Style (17th ed.) Citation

Shan, Xia, Cheng Zhang, Chunyu Li, Xingchen Fan, Guoxin Song, Jingfeng Zhu, Risheng Cao, Xiuwei Zhang, and Wei Zhu. "MiR-338-3p Acts as a Tumor Suppressor in Lung Squamous Cell Carcinoma by Targeting FGFR2/FRS2." Cancer Pathogenesis and Therapy 1, no. 2 (2023): 87-97. https://doi.org/10.1016/j.cpt.2022.12.004.

MLA (9th ed.) Citation

Shan, Xia, et al. "MiR-338-3p Acts as a Tumor Suppressor in Lung Squamous Cell Carcinoma by Targeting FGFR2/FRS2." Cancer Pathogenesis and Therapy, vol. 1, no. 2, 2023, pp. 87-97, https://doi.org/10.1016/j.cpt.2022.12.004.